In vitro studies found that ATRA could increase the uptake of arsenic trioxide by leukemia cells through upregulating a transmembrane protein aquaporin-9 (AQP9), which is recognized as a major pathway of arsenic uptake. This evidence concerns the gene AQP9 and leukemia.